These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


496 related items for PubMed ID: 17189881

  • 1. Activity of newer fluoroquinolones against gram-positive and gram-negative bacteria isolated from ocular infections: an in vitro comparison.
    Duggirala A, Joseph J, Sharma S, Nutheti R, Garg P, Das T.
    Indian J Ophthalmol; 2007; 55(1):15-9. PubMed ID: 17189881
    [Abstract] [Full Text] [Related]

  • 2. In vitro activity of fluoroquinolones against ocular bacterial isolates in São Paulo, Brazil.
    Oliveira AD, D'Azevedo PA, Francisco W.
    Cornea; 2007 Feb; 26(2):194-8. PubMed ID: 17251812
    [Abstract] [Full Text] [Related]

  • 3. [In vitro antibiotic susceptibility to fluoroquinolones].
    Wong CA, Galvis V, Tello A, Villareal D, Rey JJ.
    Arch Soc Esp Oftalmol; 2012 Mar; 87(3):72-8. PubMed ID: 22423655
    [Abstract] [Full Text] [Related]

  • 4. Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates.
    Kowalski RP, Dhaliwal DK, Karenchak LM, Romanowski EG, Mah FS, Ritterband DC, Gordon YJ.
    Am J Ophthalmol; 2003 Sep; 136(3):500-5. PubMed ID: 12967804
    [Abstract] [Full Text] [Related]

  • 5. Comparative in vitro activity of gatifloxacin, grepafloxacin, levofloxacin, moxifloxacin and trovafloxacin against 4151 Gram-negative and Gram-positive organisms.
    Blondeau JM, Laskowski R, Bjarnason J, Stewart C.
    Int J Antimicrob Agents; 2000 Feb; 14(1):45-50. PubMed ID: 10717500
    [Abstract] [Full Text] [Related]

  • 6. [Antibiotic susceptibility patterns of bacteria isolated from keratitis and intraocular infections at Fundación Oftalmológica de Santander (FOSCAL), Floridablanca, Colombia].
    Galvis V, Tello A, Guerra A, Acuña MF, Villarreal D.
    Biomedica; 2014 Apr; 34 Suppl 1():23-33. PubMed ID: 24968033
    [Abstract] [Full Text] [Related]

  • 7. Review of third-and fourth-generation fluoroquinolones in ophthalmology: in-vitro and in-vivo efficacy.
    Scoper SV.
    Adv Ther; 2008 Oct; 25(10):979-94. PubMed ID: 18836691
    [Abstract] [Full Text] [Related]

  • 8. In vitro susceptibility of bacterial keratitis isolates to fourth-generation fluoroquinolones.
    Chawla B, Agarwal P, Tandon R, Titiyal JS, Sharma N, Agarwal T, Navak N, Satpathy G.
    Eur J Ophthalmol; 2010 Oct; 20(2):300-5. PubMed ID: 19924668
    [Abstract] [Full Text] [Related]

  • 9. Comparative in-vitro efficacy of fluoroquinolones against Streptococcus pneumoniae recovered from bacterial keratitis as determined by E-test.
    Ramakrishnan R, Ramesh S, Bharathi MJ, Amuthan M, Viswanathan S.
    Indian J Pathol Microbiol; 2010 Oct; 53(2):276-80. PubMed ID: 20551532
    [Abstract] [Full Text] [Related]

  • 10. In vitro antibacterial activity of moxifloxacin against hospital isolates: a multicentre study.
    Soussy CJ, Nguyen J, Goldstein F, Dabernat H, Andremont A, Leclercq R, Drugeon H, Cavallo P, Chardon H, Etienne J, Rio Y, Courvalin P.
    Clin Microbiol Infect; 2003 Oct; 9(10):997-1005. PubMed ID: 14616741
    [Abstract] [Full Text] [Related]

  • 11. Comparison of in vitro susceptibilities of Gram-positive cocci isolated from ocular infections against the second and fourth generation quinolones at a tertiary eye care centre in South India.
    Reddy AK, Garg P, Alam MR, Gopinathan U, Sharma S, Krishnaiah S.
    Eye (Lond); 2010 Jan; 24(1):170-4. PubMed ID: 19229279
    [Abstract] [Full Text] [Related]

  • 12. In vitro and in vivo antibacterial activities of DK-507k, a novel fluoroquinolone.
    Otani T, Tanaka M, Ito E, Kurosaka Y, Murakami Y, Onodera K, Akasaka T, Sato K.
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3750-9. PubMed ID: 14638477
    [Abstract] [Full Text] [Related]

  • 13. Antibacterial activity of moxifloxacin (Bay 12-8039) against aerobic clinical isolates, and provisional criteria for disk susceptibility tests.
    Barry AL, Fuchs PC, Brown SD.
    Eur J Clin Microbiol Infect Dis; 1999 Apr; 18(4):305-9. PubMed ID: 10385024
    [Abstract] [Full Text] [Related]

  • 14. Antibacterial activity of the fourth-generation fluoroquinolones gatifloxacin and moxifloxacin against ocular pathogens.
    Callegan MC, Ramirez R, Kane ST, Cochran DC, Jensen H.
    Adv Ther; 2003 Apr; 20(5):246-52. PubMed ID: 14964344
    [Abstract] [Full Text] [Related]

  • 15. [In vitro activity of prulifloxacin, levofloxacin and ciprofloxacin against urinary pathogens].
    Noviello S, Ianniello F, Leone S, Esposito S.
    Infez Med; 2006 Mar; 14(1):24-8. PubMed ID: 17405239
    [Abstract] [Full Text] [Related]

  • 16. Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics.
    Mather R, Karenchak LM, Romanowski EG, Kowalski RP.
    Am J Ophthalmol; 2002 Apr; 133(4):463-6. PubMed ID: 11931779
    [Abstract] [Full Text] [Related]

  • 17. In vitro susceptibility of 4903 bacterial isolates to gemifloxacin--an advanced fluoroquinolone.
    Blondeau JM, Hansen G, Metzler KL, Borsos S, Irvine LB, Blanco L.
    Int J Antimicrob Agents; 2003 Aug; 22(2):147-54. PubMed ID: 12927955
    [Abstract] [Full Text] [Related]

  • 18. Comparison of in vitro susceptibilities of ocular bacterial isolates to gatifloxacin and other topical antibiotics.
    Kaliamurthy J, Nelson Jesudasan CA, Geraldine P, Parmar P, Kalavathy CM, Thomas PA.
    Ophthalmic Res; 2005 Aug; 37(3):117-22. PubMed ID: 15746568
    [Abstract] [Full Text] [Related]

  • 19. In vitro activity of gatifloxacin, a new fluoroquinolone, against 204 anaerobes compared to seven other compounds.
    Dubreuil L, Behra-Miellet J, Neut C, Calvet L.
    Clin Microbiol Infect; 2003 Nov; 9(11):1133-8. PubMed ID: 14616733
    [Abstract] [Full Text] [Related]

  • 20. Activity of moxifloxacin against pathogens with decreased susceptibility to ciprofloxacin.
    Pong A, Thomson KS, Moland ES, Chartrand SA, Sanders CC.
    J Antimicrob Chemother; 1999 Nov; 44(5):621-7. PubMed ID: 10552978
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 25.